U.S. Specialty Stores Stock News

Lennox International (LII) moved higher after reports that President Trump was considering ending the military conflict in Iran, along with stabilizing oil prices that eased worries about energy costs and industrial disruptions. See our latest analysis for Lennox International. Lennox’s 4.54% 1 day share price gain to US$464.13 follows improving sentiment around conflict risks and energy costs. However, this comes after an 18.57% 30 day share price decline and a 16.79% 1 year total...

Recently, Southern Copper outlined a long-term plan to invest nearly US$19.90 billion over the next decade to lift copper production toward about 1.6 million tons annually by 2035, even as it anticipates near-term output pressure from weaker ore grades at its Peruvian mines. This commitment highlights how one of the industry’s largest reserve holders is positioning itself to be a major future supplier of copper-intensive, energy-transition materials. We’ll now examine how Southern Copper’s...

Proto Labs (PRLB) is back in focus after reporting record quarterly revenue, 12.1% year over year revenue growth, and earnings that came in ahead of market expectations, along with guidance that topped EPS forecasts. See our latest analysis for Proto Labs. Despite the upbeat earnings news, Proto Labs has had a mixed share price run, with a 12.71% 90-day share price return and an 11.04% year-to-date share price return. The 1-year total shareholder return sits at 61.12% and the 3-year total...

If you are wondering whether Masimo at around US$177.87 is offering value or asking you to pay up for quality, this breakdown will help you frame that question clearly. The stock has been relatively steady over the last week with a 0.5% decline, modestly higher over 30 days with a 1.4% gain, and much stronger year to date with a 39.6% return, compared with a 6.1% return over the past year and a 24.2% decline over five years. Recent headlines have focused on Masimo's position in medical...

Volvo Cars has converted its outstanding shareholder loans to Polestar Automotive Holding UK (NasdaqGM:PSNY) into equity, changing the mix of Polestar’s capital structure. The two companies also agreed to concentrate future manufacturing of the Polestar 3 in the U.S., expanding their existing production collaboration. For investors watching NasdaqGM:PSNY, these moves come against a backdrop of a share price at $18.42 and a long term track record that includes a 41.5% decline over the past...

Terex stock: context for recent performance Terex (TEX) has drawn fresh attention after recent share price moves, with the stock up 0.8% over the past day, showing a 14% decline over the past month and a 10.7% gain over the past 3 months. See our latest analysis for Terex. That 7.7% 1 day share price return sits against a 14.1% 30 day share price decline and a 57.4% 1 year total shareholder return, which suggests momentum has cooled recently after a strong run for longer term holders. If...

Wondering if Coeur Mining at around US$18.77 is still giving you fair value, or if the big moves are already priced in? This article breaks down what the current market price might be implying. The stock has produced a 236.4% return over the last year and 342.7% over 3 years, while more recently showing a 2.5% return over 7 days, a 30.9% decline over 30 days, and a 7.0% return year to date. This mix of results may signal changing expectations around risk and reward. Recent coverage has...

Weyerhaeuser recently drew investor attention ahead of its past Q1 2026 earnings release, as analysts projected a sharp year-over-year drop in funds from operations and weaker quarterly profit. At the same time, analysts’ expectations for stronger funds from operations and earnings per share in fiscal 2026 and 2027 have raised questions about how short-term pressure might contrast with the longer-term outlook for the timber REIT. Next, we’ll examine how the expected Q1 2026 profit drop and...

In the past quarter, TransDigm Group reported a 13.9% year-on-year revenue increase and exceeded analyst expectations on both sales and adjusted operating income, which management described as a solid start to its 2026 fiscal year. This performance highlights the breadth of TransDigm’s installed base, with its proprietary components touching nearly all in-service aircraft across commercial and military aviation. Next, we’ll examine how TransDigm’s stronger-than-expected revenue and operating...

In late March 2026, Honeywell announced a multi-year supplier framework agreement with the U.S. Department of War to expand production of critical defense technologies, alongside a large debt tender and a new AI-powered video and access-control collaboration between Honeywell Building Automation and Rhombus initially focused on North America. Taken together, these moves highlight Honeywell’s push to modernize its balance sheet while deepening exposure to defense demand and cloud-based,...

Dollar Tree recently entered into a US$500 million term loan credit facility maturing in March 2029, with interest tied to the Term SOFR Rate plus 1.00%, flexible prepayment, and covenants linked to leverage and fixed charge coverage ratios. The new financing, combined with ongoing investment in rebuilt and newly acquired distribution centers and cloud-based supply chain technology, underscores management’s emphasis on upgrading infrastructure and inventory management capabilities. We’ll now...

If you are wondering whether Ascendis Pharma's share price still offers value after a strong run, the key is to look closely at what the current valuation actually reflects. The stock last closed at US$228.73, with returns of 6.1% over 7 days, a 2.0% decline over 30 days, 7.2% year to date, 51.0% over 1 year, 220.2% over 3 years and 73.7% over 5 years. Recent price moves have come alongside ongoing attention on Ascendis Pharma's pipeline progress and funding position, as investors reassess...

Recently, Deutsche Bank reiterated a Hold rating on Kimberly-Clark while Britain’s competition regulator began a phase 1 review of its US$3.40 billion Suzano joint venture, with a decision expected by May 28. At the same time, modest 2.5% organic sales growth and a five‑percentage‑point drop in free cash flow margin have raised fresh questions about Kimberly-Clark’s core profitability and capital needs. We’ll now examine how concerns over slowing organic sales and weaker free cash flow...

Capital raise potential and what it could mean for XPLR Infrastructure (XIFR) XPLR Infrastructure (XIFR) has filed a US$300 million shelf registration for its common units, giving the partnership flexibility to issue equity as funding needs or investment plans emerge. See our latest analysis for XPLR Infrastructure. The shelf filing comes as XIFR’s share price sits at US$10.62, with a 1 day share price return of 4.94% and a 1 year total shareholder return of 13.83%. The 3 year total...

NiSource (NI), a regulated natural gas and electric utility, is back in focus after recent share price moves that contrast a small decline over the past month with a stronger total return over the past 3 months and 1 year. See our latest analysis for NiSource. The recent 7 day share price return of 2.15% builds on a 90 day share price return of 11.73%. The 1 year total shareholder return of 18.68% sits alongside a 3 year total shareholder return of 85.44% and a 5 year total shareholder return...

Alnylam Pharmaceuticals has reported new clinical and real world data on its RNAi therapy vutrisiran in ATTR-CM, highlighting durable benefits in quality of life and reductions in advanced disease progression and mortality. The company has also shared pooled Phase 2 safety data for zilebesiran that supports its move into a global Phase 3 trial in hypertension and cardiovascular risk reduction. For investors tracking NasdaqGS:ALNY, this update centers on the company’s core RNAi franchise and...

Elanco Animal Health (NYSE:ELAN) is presenting at the World Vaccine Congress 2026. Senior leadership is discussing the company’s product development in animal vaccines. The appearance places Elanco alongside major global vaccine developers and industry experts. For you as an investor following NYSE:ELAN, this conference appearance ties directly to the company’s core focus on animal health products, including vaccines for livestock and companion animals. The World Vaccine Congress 2026 is a...

UP Fintech Holding Limited recently reported its fourth-quarter and full-year 2025 results, with Q4 revenue of US$175.57 million and net income of US$45.23 million, and full-year revenue of US$612.06 million and net income of US$170.9 million, all higher than the prior year. The sharp rise in basic earnings per share from continuing operations to US$0.96 for 2025, up from US$0.375 a year earlier, highlights a significant improvement in profitability. We will now examine how this strong...

Georgia Power, a subsidiary of Southern (NYSE:SO), has started construction on a 260 MW battery energy storage system in Jefferson County, Georgia. The company is also planning two additional large scale solar plus storage projects totaling 350 MW. These projects were approved by the Georgia Public Service Commission and are aimed at supporting grid reliability and growing power demand. For investors tracking NYSE:SO, this move adds context to a stock that has returned 10.7% year to date...

Wondering if National Health Investors is priced fairly today or if the current share price leaves some room on the table? This overview walks through what the recent numbers may be saying about value. The stock closed at US$80.86, with returns of 5.2% year to date and 14.2% over the last year, while the past 7 and 30 days have seen declines of 2.1% and 3.8% respectively. Recent coverage has focused on how real estate investment trusts are responding to changing conditions in healthcare...

BigBear.ai Holdings, Inc. has called a Special Meeting of Stockholders held on April 21, 2026, where investors voted on amending its Second Amended and Restated Certificate of Incorporation to increase authorized common stock from 500,000,000 to 1,000,000,000 shares. This large potential expansion of the share pool can reshape how the company finances future initiatives, affecting everything from capital-raising options to ownership dilution. Next, we'll examine how the proposed doubling of...

Wondering whether GEO Group at around US$16.81 is starting to look like value or a value trap? This breakdown will help you frame the stock in numbers, not noise. The share price has moved around recently, with a 0.8% decline over the past week, an 11.8% gain over 30 days, a 5.5% return year to date and a 43.8% decline over the last year, set against a 113.9% return over 3 years and 115.5% over 5 years. Recent attention on GEO Group has focused on its role in private corrections and...

In late March 2026, MKS Inc. disclosed that it had received a shareholder proposal from John Chevedden seeking the right for shareholders holding a specified ownership threshold to call special shareholder meetings, and the board urged investors to vote against it at the upcoming May 11, 2026 annual meeting. This governance dispute highlights a tension between management’s preferred control over the corporate agenda and some investors’ desire for more flexible shareholder rights. Next, we...

Sangamo Therapeutics (SGMO) closed out FY 2025 with Q4 revenue of US$14.2 million and a basic EPS loss of US$0.11, as net income excluding extra items came in at a loss of US$37.4 million. On a trailing twelve month basis, revenue was US$39.6 million with a basic EPS loss of US$0.44 and a net loss of US$122.9 million. The company has seen quarterly revenue range from US$0.6 million to US$49.4 million across the last six reported periods, with basic EPS moving between a loss of US$0.14 and a...